WHO no longer planning safety alert on Kenvue cough syrup: report [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
concerns that a batch sold in several African nations had been contaminated by the chemical diethylene glycol. The agency told Reuters that it was no longer considering the alert because the batch in question was no longer on shelves and had been consumed with no reports of adverse reactions. The product has been pulled from shelves in Nigeria, Kenya, Rwanda, Tanzania, Zimbabwe and South Africa. Contamination concerns emerged earlier this month after Nigerian regulators said diethylene glycol had been detected during routine testing of the cough syrup. The batch was later identified as being manufactured in South Africa in May 2021. No deaths have been reported in connection with the recalled batch. Benylin Paediatric Syrup was originally sold by Johnson & Johnson ( NYSE: JNJ ). The product is now sold by Kenvue, which was spun out of J&J last year. Kenvue told Seeking Alpha in an emailed statement Friday that it tested the batch of Benylin Paediatric cough syrup recalled by N
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery [Yahoo! Finance]Yahoo! Finance
- TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer [Yahoo! Finance]Yahoo! Finance
- TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer [Yahoo! Finance]Yahoo! Finance
- BIZCLIK MEDIA LAUNCHES MAY EDITION OF SUPPLY CHAIN DIGITAL AND PROCUREMENT MAGAZINE [Yahoo! Finance]Yahoo! Finance
- How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/29/24 - Form 4
- JNJ's page on the SEC website